Tyler-Stone Wealth Management’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Hold |
42,016
| – | – | 0.02% | 327 |
|
|
2025
Q1 | $120K | Hold |
42,016
| – | – | 0.02% | 315 |
|
|
2024
Q4 | $97.5K | Hold |
42,016
| – | – | 0.02% | 320 |
|
|
2024
Q3 | $132K | Buy |
42,016
+21,008
| +100% | +$66.2K | 0.03% | 313 |
|
|
2024
Q2 | $46.4K | Hold |
21,008
| – | – | 0.02% | 373 |
|
|
2024
Q1 | $65.5K | Hold |
21,008
| – | – | 0.03% | 331 |
|
|
2023
Q4 | $81.5K | Hold |
21,008
| – | – | 0.04% | 288 |
|
|
2023
Q3 | $69K | Hold |
21,008
| – | – | 0.04% | 298 |
|
|
2023
Q2 | $67K | Buy |
+21,008
| New | +$67K | 0.04% | 304 |
|
|
2022
Q4 | $89K | Hold |
21,008
| – | – | 0.06% | 249 |
|
|
2022
Q3 | $103K | Hold |
21,008
| – | – | 0.08% | 216 |
|
|
2022
Q2 | $64K | Hold |
21,008
| – | – | 0.04% | 290 |
|
|
2022
Q1 | $58K | Hold |
21,008
| – | – | 0.03% | 316 |
|
|
2021
Q4 | $62K | Buy |
+21,008
| New | +$62K | 0.03% | 327 |
|